[Benign pleural effusions in cancer patients. Frequency and etiopathogenic mechanism in a series of autopsy cases].
作者信息
Rodríguez-Panadero F, Borderas Naranjo F, López Mejías J
出版信息
Rev Clin Esp. 1988 Oct;183(6):311-2.
PMID:3217550
Abstract
摘要
相似文献
1
[Benign pleural effusions in cancer patients. Frequency and etiopathogenic mechanism in a series of autopsy cases].[癌症患者的良性胸腔积液。一系列尸检病例中的发生率及病因机制]
Rev Clin Esp. 1988 Oct;183(6):311-2.
2
Serum cancer antigen 125 in patients with pleural effusions.胸腔积液患者的血清癌抗原125
Med J Malaysia. 2006 Dec;61(5):558-63.
3
Positive effusion cytology as the initial presentation of malignancy.阳性积液细胞学检查作为恶性肿瘤的初始表现。
Acta Cytol. 1987 Jul-Aug;31(4):448-52.
4
[Benign asbestos pleural effusion. Report of a first series in Spain].[良性石棉性胸腔积液。西班牙首例系列报告]
Med Clin (Barc). 1996 Oct 26;107(14):535-8.
5
6
The accuracy and significance of cytologic cancer diagnosis of pleural effusions. (A followup study of 338 patients).胸腔积液细胞学癌症诊断的准确性及意义。（对338例患者的随访研究）
Acta Cytol. 1972 Mar-Apr;16(2):152-8.
7
[Pleural effusion in cancer patients. Review of 118 cases].[癌症患者的胸腔积液。118例病例回顾]
Med Clin (Barc). 1983 May 28;80(19):823-5.
8
9
Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.CYFRA21-1、NSE、CA15-3、CA19-9和CA125检测在老年胸腔积液患者中的临床价值
Int J Clin Pract. 2007 Mar;61(3):444-8. doi: 10.1111/j.1742-1241.2006.01111.x.
10
Evaluation of CYFRA 21-1 in malignant and benign pleural effusions.细胞角蛋白19片段21-1（CYFRA 21-1）在恶性和良性胸腔积液中的评估
Anticancer Res. 1996 Jul-Aug;16(4A):2101-4.
引用本文的文献
1
Contemporary best practice in the management of malignant pleural effusion.恶性胸腔积液管理的当代最佳实践。
Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618785098. doi: 10.1177/1753466618785098.
Zotero 插件